Gatifloxacin-Associated Corrected QT Interval Prolongation, Torsades de Pointes, and Ventricular Fibrillation in Patients with Known Risk Factors | Zendy

Joseph Bertino | Zendy; Robert C. Owens | Zendy; Timothy D. Carnes | Zendy; Paul B. Iannini | Zendy

Open Access

Gatifloxacin-Associated Corrected QT Interval Prolongation, Torsades de Pointes, and Ventricular Fibrillation in Patients with Known Risk Factors

Author(s) -

Joseph Bertino,

Robert C. Owens,

Timothy D. Carnes,

Paul B. Iannini

Publication year - 2002

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/339075

Subject(s) - torsades de pointes , medicine , gatifloxacin , qt interval , prolongation , cardiology , ventricular fibrillation , ciprofloxacin , biology , bacteria , genetics

Drugs not commonly considered to be cardioactive agents have been reported to cause prolongation of the corrected QT interval with resultant torsades de pointes or ventricular fibrillation. We report 4 cases of gatifloxacin-associated cardiac toxicity in patients with known risk factors for this adverse event.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research